Vaccines for the Elderly: The Quest for the Ideal Animal Model

Journal of Comparative Pathology

Volumn 142, Issue SUPPL. 1, 2010, Pages

  Boudet, F ^a  

^a SANOFI PASTEUR   (France)

Author keywords

animal model; man; vaccine

Indexed keywords

VACCINE;

AGED; DRUG RESEARCH; DRUG SCREENING; ELDERLY CARE; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; VACCINATION; VACCINE FAILURE;

AGED; AGING; ANIMALS; HUMANS; MICE; MODELS, ANIMAL; VACCINATION; VACCINES;

ANIMALIA; MURINAE;

EID: 73249136449     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.10.005     Document Type: Review

References (32)

1. Arora S., Sharma S., Goel S.K., and Singh U.S. Effect of different adjuvants in equines for the production of equine rabies immunoglobulins. National Medical Journal of India 18 (2005) 289-292
2. Asanuma H., Hirokawa K., Uchiyama M., Suzuki Y., Aizawa C., et al. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine 19 (2001) 3981-3989
3. Aspinall R., Pido-Lopez J., Imami N., Henson S.M., Ngom P.T., et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Research 10 (2007) 5-17
4. Barbour A.H., Rampling A., and Hormaeche C.E. Comparison of the infectivity of isolates of Listeria monocytogenes following intragastric and intravenous inoculation in mice. Microbial Pathogenesis 20 (1996) 247-253
5. De Donato S., Granoff D., Minutello M., Lecchi G., Faccini M., et al. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine 17 (1999) 3094-3101
6. Deng Y., Jing Y., Campbell A.E., and Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. Journal of Immunology 172 (2004) 3437-3446
7. Gandy S. Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates. Current Opinion in Immunology 16 (2004) 607-615
8. Gerdts V., Littel-van den Hurk S.D., Griebel P.J., and Babiuk L.A. Use of animal models in the development of human vaccines. Future Microbiology 2 (2007) 667-675
9. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2006) 1159-1169
10. Hein W.R., and Griebel P.J. A road less travelled: large animal models in immunological research. Nature Reviews Immunology 3 (2003) 79-84
11. Hein W.R., and Mackay C.R. Prominence of gamma delta T cells in the ruminant immune system. Immunology Today 12 (1991) 30-34
12. Higgins D.A., Carlson J.R., and Van Nest G. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. Vaccine 14 (1996) 478-484
13. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. Journal of Infectious Diseases 198 (2008) 650-658
14. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 (2005) 1165-1174
15. Kovaiou R.D., Herndler-Brandstetter D., and Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Reviews in Molecular Medicine 9 (2007) 1-17
16. Kumar R., and Burns E.A. Age-related decline in immunity: implications for vaccine responsiveness. Expert Review of Vaccines 7 (2008) 467-479
17. Marco A.J., Prats N., Ramos J.A., Briones V., Blanco M., et al. A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. Journal of Comparative Pathology 107 (1992) 1-9
18. Mbawuike I.N., Acuna C., Caballero D., Pham-Nguyen K., Gilbert B., et al. Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A. Cellular Immunology 173 (1996) 64-78
19. McElhaney J.E. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23 (2005) S10-S25
20. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408 (2000) 982-985
21. Muirhead T.L., McClure J.T., Wichtel J.J., Stryhn H., Frederick Markham R.J., et al. The effect of age in serum antibody titers after rabies and influenza vaccination in healthy horses. Journal of Veterinary Internal Medicine 22 (2008) 654-661
22. Orgogozo J.M., Gilman S., Dartigues J.F., Laurent B., Puel M., et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61 (2003) 46-54
23. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 19 (2001) 2673-2680
24. Posnett D.N., Engelhorn M.E., Lin Y., Merghoub T., Duan F., et al. Development of effective vaccines for old mice in a tumor model. Vaccine 27 (2009) 1093-1100
25. Saalmüller A., Pauly T., Höhlich B.J., and Pfaff E. Characterization of porcine T lymphocytes and their immune response against viral antigens. Journal of Biotechnology 73 (1999) 223-233
26. Sambhara S., Kurichh A., Miranda R., Tamane A., Arpino R., et al. Enhanced immune responses and resistance against infection on aged mice conferred by Flu-ISCOMs vaccine correlate with up-regulation of costimulatory molecule CD86. Vaccine 16 (1998) 1698-1704
27. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
28. Subbarao K., and Roberts A. Is there an animal ideal model for SARS?. Trends in Microbiology 14 (2006) 299-303
29. Takamatsu H.H., Denyer M.S., Stirling C., Cox S., Aggarwal N., et al. Porcine gamma delta T cells: possible roles on the innate and adaptive immune responses following virus infection. Veterinary Immunology and Immunopathology 112 (2006) 49-61
30. Vila-Corcoles A. Advances in pneumococcal vaccines: what are the advantages for the elderly?. Drugs and Aging 24 (2007) 791-800
31. Vogel L.N., Roberts A., Paddock C.D., Genrich G.L., Lamirande E.W., et al. Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV). Vaccine 25 (2007) 2173-2179
32. Zhang Y., Wang Y., Gilmore X., Xu K., Wyde P.R., et al. An aged mouse model for RSV infection and diminished CD8 + CTL responses. Experimental Biology and Medicine 227 (2002) 133-140